Germany’s OTC Market in 2018: Online Sees Double-Digit Growth, Bionorica’s Canephron Uno Tops New Launches
Executive Summary
Germany's online channel continued to expand to expand in 2018, with OTC product sales via mail-order pharmacy growing almost 10-times faster than through bricks-and-mortar pharmacy. Meanwhile, GSK's Voltaren brand was top-seller through both channels and Bionorica's Canephron Uno was the best-selling launch during the 12 months.
You may also be interested in...
France's Boiron Strikes Deal With Bionorica As Q3 Sales Edge Up
Boiron has gained the rights to distribute Bionorica's Canephron herbal medicine in France as it continues to diversify its portfolio away from homeopathy.
Zantac Recall And EU Regulatory Issues Hurt Sanofi In Q3
Recalling Zantac in North America over contamination concerns and tightening regulatory requirements in Europe combined to impede growth at Sanofi Consumer Healthcare in Q3. New CEO Paul Hudson says he is still taking time to get to know the business before making any strategic moves.
EU Deal Tracker: Polpharma And JGL Join Forces, PharmaNutra Expands Reach, Bionorica Divests Cannabis Unit
Polphama and JGL have struck a deal to distribute one another's ophthalmology products, PharmaNutra has secured expanded distribution for its Cetilar joint pain product, and Bionorica has offloaded its cannabis business to Canada's Canopy.